🟢 EIQ.XA is trading 39% up today on leadership appointments to drive U.S. growth and FDA strategy

EIQ.XA is trading 39% up at $1.73 following the announcement of key leadership appointments aimed at accelerating U.S. commercial growth and FDA-related initiatives.

• Echo IQ Limited appointed Matthew Dodds as CFO and a senior clinical leader to strengthen the company’s executive team and regulatory focus.
• The move signals a major strategic push into the U.S. market, which investors are treating as a significant upgrade to the company's commercial roadmap.
• The sharp price action reflects market confidence in the newly established leadership's ability to navigate the FDA regulatory pathway.